Mirum Pharmaceuticals, Inc. (MIRM) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Biotechnology उद्योग. कंपनी का मुख्यालय है Foster City, CA, United States. वर्तमान CEO हैं Christopher Peetz.
MIRM के पास है IPO तिथि 2019-07-18, 334 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Global Market, बाजार पूंजीकरण $4.86B.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing novel therapies for rare and orphan diseases affecting the liver and bile system. The company's lead product candidate, LIVMARLI, is an investigational oral medication designed to treat progressive familial intrahepatic cholestasis, Alagille syndrome, and biliary atresia. Mirum also develops Volixibat for the treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018 and headquartered in Foster City, California, Mirum focuses on addressing critical unmet needs in hepatobiliary diseases.
